tiprankstipranks
Canopy Growth (TSE:WEED)
TSX:WEED
Canadian Market

Canopy Growth (WEED) Earnings Dates, Call Summary & Reports

Compare
2,094 Followers

Earnings Data

Report Date
May 30, 2025
TBA Not Confirmed
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.39
Last Year’s EPS
-1.03
Same Quarter Last Year
Moderate Sell
Based on 6 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 07, 2025
|
% Change Since: -40.85%
|
Next Earnings Date:May 30, 2025
Earnings Call Sentiment|Neutral
Canopy Growth demonstrated strong performance in medical cannabis and launched successful new products like Claybourne. However, challenges in adult use revenue, overall revenue decline, and increased competition in Australia highlight the difficulties faced. Despite these challenges, the company showed significant improvement in profitability and cash flow, indicating a positive trend towards achieving sustained profitability.
Company Guidance
During Canopy Growth's third-quarter fiscal 2025 earnings call, the company provided several key metrics and insights into its performance and future outlook. Consolidated net revenue for the quarter was CAD75 million, marking a 5% decrease year-over-year, or an 8% increase excluding divested businesses. The gross margin stood at 32%, down from 36% the previous year. However, the adjusted EBITDA loss significantly narrowed to CAD3 million, a 61% improvement compared to the same quarter last year, while free cash flow was an outflow of CAD28 million, a 17% improvement year-over-year. The Canadian market saw net revenue of CAD41 million, with notable growth in the medical cannabis segment, up 16%, and an increase in adult-use revenue by 15% quarter-over-quarter. International markets, particularly in Europe, showed promising growth with a 14% year-over-year increase in net revenue, driven by strong performance in Poland and Germany. The Storz & Bickel segment also performed robustly, with a 19% increase in revenue, totaling CAD22 million for the quarter. The company indicated that achieving positive adjusted EBITDA is within reach in the coming quarters and highlighted ongoing efforts to improve profitability and cash flow into fiscal 2026.
Medical Cannabis Success
In Canada, medical cannabis business posted record revenue with 16% year-over-year growth. Internationally, Canopy Growth has a strong position in markets like Germany, Poland, and Australia, with European markets experiencing over 70% growth.
Launch of Claybourne Brand
In less than six weeks, the Claybourne brand became the number three infused pre-roll in British Columbia and Ontario, indicating successful market penetration and consumer acceptance.
Storz & Bickel Performance
Storz & Bickel reported a 19% revenue increase to CAD22 million in Q3, driven by robust direct-to-consumer online sales and strong performance in Germany.
Improved EBITDA and Cash Flow
Adjusted EBITDA loss improved by 61% to CAD3 million, and free cash flow outflow improved by 17% to CAD28 million compared to Q3 of fiscal '24.
Successful Cost Reductions
Sales and marketing and G&A expenses declined 24% year-over-year, with significant progress in reducing cash costs related to legacy facilities.
---

Canopy Growth (TSE:WEED) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:WEED Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 30, 20252025 (Q4)
-0.39 / -
-1.03
Feb 07, 20252025 (Q3)
-0.47 / -1.11
-2.6257.63% (+1.51)
Nov 08, 20242025 (Q2)
-0.46 / -1.48
-4.365.58% (+2.82)
Aug 09, 20242025 (Q1)
-0.46 / -1.60
-0.7-128.57% (-0.90)
May 30, 20242024 (Q4)
-0.44 / -1.03
-12.891.95% (+11.77)
Feb 09, 20242024 (Q3)
-0.50 / -2.62
-5.451.48% (+2.78)
Nov 09, 20232024 (Q2)
-1.57 / -4.30
-4.78.51% (+0.40)
Aug 09, 20232024 (Q1)
-1.77 / -0.70
-52.398.66% (+51.60)
Jun 22, 20232023 (Q4)
-2.08 / -12.80
-14.612.33% (+1.80)
Feb 09, 20232023 (Q3)
-2.21 / -5.40
-2.8-92.86% (-2.60)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TSE:WEED Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 07, 2025C$3.99C$2.89-27.57%
Nov 08, 2024C$6.30C$5.90-6.35%
Aug 09, 2024C$9.49C$8.70-8.32%
May 30, 2024C$11.59C$11.78+1.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Canopy Growth (TSE:WEED) report earnings?
Canopy Growth (TSE:WEED) is schdueled to report earning on May 30, 2025, TBA Not Confirmed.
    What is Canopy Growth (TSE:WEED) earnings time?
    Canopy Growth (TSE:WEED) earnings time is at May 30, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:WEED EPS forecast?
          TSE:WEED EPS forecast for the fiscal quarter 2025 (Q4) is -0.39.
            ---

            Canopy Growth (TSE:WEED) Earnings News

            Canopy Growth Stock (TSE:WEED) Plunges after Disappointing Q4 Earnings
            Premium
            Market News
            Canopy Growth Stock (TSE:WEED) Plunges after Disappointing Q4 Earnings
            2y ago
            CGC Craters on Weak Earnings; Lays Off 60% of Workforce
            Premium
            Market News
            CGC Craters on Weak Earnings; Lays Off 60% of Workforce
            2y ago
            Canopy (Non) Growth: Weed Company Disappoints Again in Fiscal Q2
            Premium
            Market News
            Canopy (Non) Growth: Weed Company Disappoints Again in Fiscal Q2
            2y ago
            Canopy Growth Stock Recovers from Earnings Miss; Shares Up 15%
            Premium
            Market News
            Canopy Growth Stock Recovers from Earnings Miss; Shares Up 15%
            3y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis